Target intelligence / Profile preview

Cholesterol Metabolism & Antioxidant Systems

Molecular classification
Biological Pathway, Metabolic System
01

Overview

Cholesterol Metabolism & Antioxidant Systems refer to the integrated biochemical networks that regulate lipid levels and cellular redox balance. Cholesterol metabolism is centered on the endogenous synthesis of cholesterol via the mevalonate pathway and its subsequent transport via lipoproteins (StatPearls, 2023). Antioxidant systems, including enzymes like glutathione peroxidase and superoxide dismutase, protect cellular components from oxidative damage caused by reactive oxygen species (NCBI, 2022). The intersection of these systems is vital in vascular health, as the oxidation of low-density lipoprotein (LDL) is a key step in the development of atherosclerotic plaques (PubMed, 2021). Therapeutic strategies often involve lowering cholesterol through HMG-CoA reductase inhibitors (statins) or enhancing antioxidant defenses to prevent chronic inflammatory diseases (Journal of Lipid Research, 2020). As this term describes a collection of pathways rather than a single protein or receptor, it is not considered a discrete therapeutic target.

Other names
Lipid metabolism and redox homeostasisCholesterol-antioxidant axisLipid peroxidation defense systems
02

Mechanism of action

Drugs targeting these systems typically inhibit HMG-CoA reductase to decrease cholesterol synthesis, block NPC1L1 to reduce cholesterol absorption, or activate Nrf2-mediated transcription of antioxidant enzymes to mitigate oxidative stress.

03

Biological functions

Lipid homeostasisRedox regulationCellular signalingMetabolic regulation
04

Disease associations

AtherosclerosisCardiovascular diseaseMetabolic syndromeHypercholesterolemiaNeurodegenerative disease
05

Safety considerations

Statin-associated muscle symptoms (SAMS)Potential for hepatotoxicityRisk of new-onset diabetes with intensive statin therapyParadoxical pro-oxidant effects of certain antioxidant supplements
06

Interacting drugs

Atorvastatin

5 more in the full profile.

07

Biomarkers

Low-density lipoprotein cholesterol (LDL-C)Oxidized LDL (oxLDL)Malondialdehyde (MDA)Glutathione peroxidase (GPx) activitySuperoxide dismutase (SOD) levels

Beyond the preview

Go deeper on Cholesterol Metabolism & Antioxidant Systems.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cholesterol Metabolism & Antioxidant Systems.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call